Government Funding Could Be HUGE for $IVOB!
September 4th, 2009 at 12:01 am Posted by The Dean
INVO Bioscience (OTC: IVOB) is focusing their efforts on one product and has a plan to treat infertility around the world and The Dean thinks they could be well on their way.
All the around the world, infertility is an issue that has 150 million couples looking for a more effective and less expensive treatment alternative.
About a week ago, The Dean brought his students attention to Michael Vlaicu’s analysis of $IVOB. This report discussed $IVOB‘s MASSIVE potential for cashing in big by successfully treating 5% of the world’s infertile couples.
The Dean liked the math so much that he figured he’d remind his students that if $IVOB successfully treats just 5% of the world’s 150 million infertile couples, $IVOB could see revenues of $4.7 billion.
So figure even if $IVOB is only able to treat 1% of the world’s infertility couples with their innovative INVOcell procedure, $IVOB still has potential to become The Dean’s Billion Dollar Baby.
The Dean has done and his homework and has found that people are starting families later in life and this makes conception more difficult and could make $IVOB‘s INVOcell procedure more DESIRABLE.
A recent article from Emaxhealth says that women 34 to 39 years old have a 15% chance of infertility and that number doubles to 30% for 40 year old women. The Dean thinks this could bring an increase in NEED for infertility treatments and this could also be good for $IVOB.
Another factor that could make $IVOB‘s infertility treatment more necessary is infertility in males. And an article published yesterday said that men who are 20 pounds or more overweight increase their chances of infertility by 10% and The Dean’s students know from learning about $VNTA that the world’s population is becoming more obese every year.
The Dean’s continually excited about $IVOB because the company has already met with government health agencies like Health Canada to discuss possible exceptions and regulations for $IVOB‘s INVOcell procedure.
And recent news reports that government funding for IVF treatments is being discussed in Ontario where a decrease in multiple births could save the government $550 million a year—and that’s just one province in Canada!
Other provinces in Canada like Quebec have already decided that government would fund up to 3 IVF cycles and entire countries like Belgium, Sweden, Denmark and Australia also fund IVF.
The Dean thinks this could be HUGE for $IVOB because governments all over the world could look to the INVOcell treatment to solve their infertility problems and save money.
Sounds like a WIN-WIN situation for everyone—including the CollegeStock Community!
Sign up to become The Dean’s newest Honors Student and receive access to The Dean’s Ivy League Stock Picks before the rest of the CollegeStock Community.
The Dean is so accessible that you can even connect with him by texting ‘thedean’ to 69302 on your wireless phone. Try it TODAY!
IVOB is definitely still on my watchlist.
The market which $IVOB is targeting is very crucial as there are around 150 million couples are looking for way to get their happiness by means of getting child. The solution is going to be economical for couples.
$IVOB’s target is 5% which is very massive, it can be billions of dollars.
I am with Dean and also exited about the $IVOB. $IVOB has their research very well and targeting age group where there are more chances of occurences.
The main reason behind my interest in $IVOB is if success is as less as 5% even in that case they will be able to create wealth of millions of dollars.
$IVOB is getting good support from Canada govt. which are signs of healthy developments.Ultimately, I am hoping to get good returns on $IVOB.